BioWin Days 2025

23–24 Sept 2025 | Namur, Belgium

HomeAgendaPartnering

Gael Debauve

Head of Gene therapy Analytical Sciences

UCB

Braine l'Alleud, Belgium

13 profile visits

My organisation

UCB

UCB

Company

Braine l'Alleud, Belgium

We are UCB, a global biopharmaceutical company founded in 1928 and employing approximately 9000 people in headquarters in Belgium and across nearly 40 countries worldwide. Our company is dedicated to transforming the lives of people with severe diseases. Our focus lies in innovative research and development, aimed at providing breakthrough solutions in neurology and immunology. We collaborate closely with healthcare professionals, partners, and communities to deliver meaningful advancements and enhance patient care. Together, we strive to make a real difference in the lives of individuals and families affected by complex health challenges.
Read more

About me

Gaël is working in Quality Control roles within the Biotech industry for 16+ years, including 9 years supporting bioassay development. Since Feb 2020, he is leading the Gene Therapy Analytical Sciences team where the focus is to build a solid analytical package to characterize and release viral vector-based gene therapy products. Gaël holds a Ph.D. in Biomedical Sciences (University of Mons, Belgium) and a master’s degree in management (Louvain School of Management, Belgium). On top of the activities at UCB, Gael is Associate Professor at the University of Mons (Belgium) and is contributing to Official International Organizations both in Europe (European Directorate for the Quality of Medicines and HealthCare (EDQM, mAb & GT Product working parties), Belgian Pharmacopeia Commission) and in the US (US Pharmacopeia (USP AAV Gene Therapy Expert Panel and Biologics Stakeholder Forum Steering Committee)).

Social media